.2001 .WHO global strategy for the containment of antimicrobial resistance. , : .
Girou E,Rioux C,Brun-Buisson C,Lobel B. .2006 .The postoperative bacteriuria score: a new way to predict nosocomial infection after prostate surgery. Infect Control Hosp Epidemiol, 27(8) : 847-54.
.2010 .WHO Laboratory Manual for the Examination. Processing of Human Semen. 5th Edition, : .
. .Performance standards for antimicrobial susceptibility testing; 2010 eighteenth informational supplement M100-S18. , : .
Van der Mee-Marquet N,Savoyen P .2010 .CTX-M-type fluoroquinolone-resistant Escherichia coli: analysis of the colonization of residents and inanimate surfaces 1 year after a first case of urinary tract infection a nursing home in France. Infect Control Hosp Epidemiol, 31(9) : 968-70.
Rattanaumpawan P,Tolomeo P,Bilker WB,Fishman NO,Lautenbach E .2010 .Risk factors for fluoroquinolone resistance in Gram negative bacilli causing healthcareacquired urinary tract infections. J Hosp Infect, 76(4) : 324-7.
Alo Moses N,Ugah Uchenna I,Elom Michael O. Semen I .2013 .Culture: A Comparative Analysis between Solid Media and Liquid Media Supplementation. J Pharm Biol Sci, 5(5) : 67-72.
Fomda BA,Thokar MA,Khan A,Bhat JA .2014 .Nasal carriage of Methicillin-resistant Staphylococcus aureus among healthy population of Kashmir. Indian J Med Microbiol, 32(1) : 39-43.
Ena J,Dick RW,Jones RN,Wenzel RP .1993 .The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA, 269(5) : 598-602.
Tarai B,Das P,Kumar D,Physicians J Lab .2013 .Recurrent Challenges for Clinicians: Emergence of MethicillinResistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options. , 5(2) : 71-8.
Melzer M,Petersen I. .2007 .Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect, 55(3) : 254-9.
Rambabu V.,Rajasekhar K.,Kumar Reddy N. Dinesh,Kumar G. Santhosh .2015 .Study on Surgical Site Infections Caused By Esbl Producing Gram Negative Bacteria. Journal of Evidence based Medicine and Healthcare, 2(38) : 6092-6097.
Maraki S,Samonis G,Rafailidis PI,Vouloumanou EK,Mavromanolakis E,Falagas ME .2009 .Susceptibility of Urinary Tract Bacteria to Fosfomycin. , 53(10) : 4508-4510.
Tantry BA,Rahiman S. .2012 .Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley. West Indian Med, 61(7) : 703-7.
Patterson DL,Ko WC,Von Gottberg A .2001 .Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extendedspectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol, 39(6) : 2206-12.
Quale JM,Landman D,Bradford PA .2002 .Molecular epidemiology of a citywide outbreak of extendedspectrum b-lactamase-producing Klebsiella pneumoniae infection. Clin Infect Dis, 35(7) : 834-41.
Yigit H,Queenan AM,Anderson GJ .2001 .Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother, 45(4) : 1151-61.
Falagas ME,Kasiakou SK .2005 .Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis, 40(9) : 1333-41.
Collins VL,Marchaim D,Pogue JM,Moshos J,Bheemreddy S,Sunkara B .2012 .Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother, 56(4) : 2173-7.
Dalgic N,Sancar M,Bayraktar B,Dincer E,Pelit S .2011 .Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children. Scand J Infect Dis, 43(5) : 339-43.
.2009 .Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenemresistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep, 58(10) : 256-60.
Bleasdale SC,Trick WE,Gonzalez IM,Lyles RD,Hayden MK,Weinstein RA .2007 .Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med, 167(19) : 2073-9.
Borer A,Gilad J,Porat N,Megrelesvilli R,Saidel-Odes L,Peled N .2007 .Impact of 4% chlorhexidine wholebody washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect, 67(2) : 149-55.
Climo MW,Sepkowitz KA,Zuccotti G,Fraser VJ,Warren DK,Perl TM .2009 .The effect of daily bathing with chlorhexidine on the acquisition of methicillinresistant Staphylococcus aureus, vancomycin resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med, 37(6) : 1858-65.